AI30924/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1992	2
1993	3
1995	1
1996	1
1997	2
1998	1
2001	3
2024	0

1

Infection with the human immunodeficiency virus type 2.

Markovitz DM. Markovitz DM. Ann Intern Med. 1993 Feb 1;118(3):211-8. doi: 10.7326/0003-4819-118-3-199302010-00010. Ann Intern Med. 1993. PMID: 8380244 Review.

2

The human LON protease binds to mitochondrial promoters in a single-stranded, site-specific, strand-specific manner.

Fu GK, Markovitz DM. Fu GK, et al. Biochemistry. 1998 Feb 17;37(7):1905-9. doi: 10.1021/bi970928c. Biochemistry. 1998. PMID: 9485316

3

Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1.

Markovitz DM, Hannibal MC, Smith MJ, Cossman R, Nabel GJ. Markovitz DM, et al. J Virol. 1992 Jun;66(6):3961-5. doi: 10.1128/JVI.66.6.3961-3965.1992. J Virol. 1992. PMID: 1533884 Free PMC article.

4

GLI-2 modulates retroviral gene expression.

Smith MJ, Gitlin SD, Browning CM, Lane BR, Clark NM, Shah N, Rainier S, Markovitz DM. Smith MJ, et al. J Virol. 2001 Mar;75(5):2301-13. doi: 10.1128/JVI.75.5.2301-2313.2001. J Virol. 2001. PMID: 11160733 Free PMC article.

5

Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation.

Hilfinger JM, Clark N, Smith M, Robinson K, Markovitz DM. Hilfinger JM, et al. J Virol. 1993 Jul;67(7):4448-53. doi: 10.1128/JVI.67.7.4448-4453.1993. J Virol. 1993. PMID: 8510231 Free PMC article.

6

Human GLI-2 is a tat activation response element-independent Tat cofactor.

Browning CM, Smith MJ, Clark NM, Lane BR, Parada C, Montano M, KewalRamani VN, Littman DR, Essex M, Roeder RG, Markovitz DM. Browning CM, et al. J Virol. 2001 Mar;75(5):2314-23. doi: 10.1128/JVI.75.5.2314-2323.2001. J Virol. 2001. PMID: 11160734 Free PMC article.

7

The sequence and structure of the 3' arm of the first stem-loop of the human immunodeficiency virus type 2 trans-activation responsive region mediate Tat-2 transactivation.

Browning C, Hilfinger JM, Rainier S, Lin V, Hedderwick S, Smith M, Markovitz DM. Browning C, et al. J Virol. 1997 Oct;71(10):8048-55. doi: 10.1128/JVI.71.10.8048-8055.1997. J Virol. 1997. PMID: 9311903 Free PMC article.

8

The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells.

Clark NM, Hannibal MC, Markovitz DM. Clark NM, et al. J Virol. 1995 Aug;69(8):4854-62. doi: 10.1128/JVI.69.8.4854-4862.1995. J Virol. 1995. PMID: 7609053 Free PMC article.

9

Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor.

Clark NM, Smith MJ, Hilfinger JM, Markovitz DM. Clark NM, et al. J Virol. 1993 Sep;67(9):5522-8. doi: 10.1128/JVI.67.9.5522-5528.1993. J Virol. 1993. PMID: 8350410 Free PMC article.

10

Purification of the pets factor. A nuclear protein that binds to the inducible TG-rich element of the human immunodeficiency virus type 2 enhancer.

Fu GK, Markovitz DM. Fu GK, et al. J Biol Chem. 1996 Aug 9;271(32):19599-605. doi: 10.1074/jbc.271.32.19599. J Biol Chem. 1996. PMID: 8702655 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year